Supplementary Figures 1 from Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
Authors:
- Madeline GoughMGMadeline Gough
- Kayden K.X. KwahKKKayden K.X. Kwah
- Tashbib KhanTKTashbib Khan
- Saikat GhoshSGSaikat Ghosh
- Biao SunBSBiao Sun
- Catherine Y.J. LeeCLCatherine Y.J. Lee
- Kamil A. SokolowskiKSKamil A. Sokolowski
- Brian W.C. TseBTBrian W.C. Tse
- Lashith WickramasuriyaLWLashith Wickramasuriya
- Kaltin FergusonKFKaltin Ferguson
- Rebecca RogersRRRebecca Rogers
- Justin B. GohJGJustin B. Goh
Open Access
- 13 May 2025
- other
- Published by American Association for Cancer Research (AACR)